HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thidarut Boonmars Selected Research

Dimethylnitrosamine (Nitrosodimethylamine)

3/2014Sex differences in opisthorchiosis and the development of cholangiocarcinoma in Syrian hamster model.
2/2014Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma.
1/2013Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine.
3/2012Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
1/2012Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma.
6/2011Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine.
1/2011Indirect effect of a turmeric diet: enhanced bile duct proliferation in Syrian hamsters with a combination of partial obstruction by Opisthorchis viverrini infection and inflammation by N-nitrosodimethylamine administration.
10/2009Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thidarut Boonmars Research Topics

Disease

28Cholangiocarcinoma
08/2023 - 01/2012
24Neoplasms (Cancer)
12/2021 - 10/2009
23Opisthorchiasis
08/2023 - 08/2009
20Infections
01/2024 - 02/2003
9Carcinogenesis
01/2016 - 10/2009
6Inflammation (Inflammations)
08/2023 - 04/2008
5Neoplasm Metastasis (Metastasis)
09/2021 - 04/2012
4Parasitic Diseases (Parasitic Disease)
12/2023 - 12/2013
4Fibrosis (Cirrhosis)
08/2023 - 08/2009
4Cysts
06/2020 - 04/2012
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 12/2016
1Hookworm Infections (Hookworm Infection)
12/2023
1Pain (Aches)
12/2021
1Wounds and Injuries (Trauma)
11/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Malaria
02/2018
1Bile Duct Neoplasms (Bile Duct Cancer)
01/2018
1Virus Diseases (Viral Diseases)
01/2016

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
04/2020 - 11/2009
10Biomarkers (Surrogate Marker)IBA
02/2018 - 10/2009
8Dimethylnitrosamine (Nitrosodimethylamine)IBA
03/2014 - 10/2009
7Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2021 - 01/2011
6Praziquantel (Biltricide)FDA Link
10/2022 - 04/2008
5Keratin-19 (Keratin 19)IBA
12/2021 - 10/2013
4DNA (Deoxyribonucleic Acid)IBA
02/2018 - 04/2012
3AnthelminticsIBA
12/2022 - 12/2013
3CurcuminIBA
01/2018 - 11/2009
3Caspase 9IBA
12/2017 - 11/2009
3Messenger RNA (mRNA)IBA
01/2016 - 08/2012
3AntioxidantsIBA
07/2015 - 01/2011
3AntibodiesIBA
01/2015 - 03/2012
3Indicators and Reagents (Reagents)IBA
12/2014 - 04/2012
3EnzymesIBA
08/2014 - 03/2004
3Prednisolone (Predate)FDA LinkGeneric
10/2013 - 06/2012
2Formaldehyde (Formol)FDA Link
12/2023 - 11/2016
2AgarIBA
12/2023 - 02/2020
2Caspase 3 (Caspase-3)IBA
01/2020 - 12/2017
2forbesioneIBA
12/2017 - 12/2016
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2017 - 01/2016
2MicroRNAs (MicroRNA)IBA
08/2017 - 12/2014
2BerberineIBA
01/2017 - 12/2013
2GemcitabineFDA Link
01/2017 - 07/2015
2Oncogene Proteins (Oncogene Protein)IBA
01/2016 - 06/2011
2CreatinineIBA
12/2013 - 07/2012
2Ethanol (Ethyl Alcohol)IBA
08/2013 - 06/2013
2Platelet-Derived Growth FactorIBA
10/2012 - 03/2012
2Cyclin D1IBA
04/2012 - 10/2009
1Glycerol (Glycerine)FDA LinkGeneric
01/2024
1ethyl acetateIBA
12/2023
1Nitroso CompoundsIBA
08/2023
1NitratesIBA
08/2023
1NitritesIBA
08/2023
1Eosine Yellowish-(YS) (Eosin)IBA
12/2021
1Hematoxylin (Haematoxylon)IBA
12/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
12/2021
1MucinsIBA
09/2021
1isomorellinIBA
02/2021
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2021
1Mitogen-Activated Protein KinasesIBA
02/2021
1p38 Mitogen-Activated Protein KinasesIBA
02/2021
1Protein Kinase CIBA
02/2021
1Focal Adhesion Protein-Tyrosine KinasesIBA
02/2021
1NanogelsIBA
11/2020
1miltefosine (Impavido)IBA
06/2020
1Chromomycin A3IBA
04/2020
1Ophthalmic Solutions (Eye Drops)IBA
02/2020
1Gatifloxacin (Zymar)FDA Link
02/2020
1Trypan BlueFDA Link
02/2020
1Levofloxacin (Levaquin)FDA Link
02/2020
1Gentamicins (Gentamicin)FDA LinkGeneric
02/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1ErbB Receptors (EGF Receptor)IBA
01/2020
1Polysaccharides (Glycans)IBA
02/2018
1sophora japonica agglutininIBA
02/2018
1Edetic Acid (EDTA)FDA Link
02/2018
1AcetylgalactosamineIBA
02/2018
1VaccinesIBA
01/2018
1Fluorouracil (Carac)FDA LinkGeneric
12/2017
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
12/2017
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
12/2017
1Peptide Hydrolases (Proteases)FDA Link
12/2017
1lissamine rhodamine B (sulforhodamine B)IBA
12/2017
1mangostinIBA
01/2017
1Cyclin EIBA
12/2016
1SurvivinIBA
12/2016
1Cyclin-Dependent Kinase 2IBA
12/2016
1Cyclin AIBA
12/2016
1Ether (Diethyl Ether)IBA
11/2016
1Small Interfering RNA (siRNA)IBA
01/2016
1AntigensIBA
01/2016
1Homogentisate 1,2-Dioxygenase (Homogentisate 1,2 Dioxygenase)IBA
01/2015
1AutoantibodiesIBA
01/2015
1isocitric acid (isocitrate)IBA
01/2015

Therapy/Procedure

5Therapeutics
12/2016 - 10/2009
3Drug Therapy (Chemotherapy)
01/2018 - 01/2013
2Traditional Medicine (Folk Remedies)
07/2015 - 12/2013
1Bathroom Equipment
12/2022
1Transplantation
09/2021
1Chemoprevention
01/2018
1Aftercare (After-Treatment)
07/2015